Sunesis Pharmaceuticals (SNSS) to Present Phase 3 VALOR Trial Data at ASH
Tweet Send to a Friend
Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that results from the Company's Phase 3 VALOR trial of vosaroxin and cytarabine ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
